New universal flu vaccine targets conserved region of viral surface protein
December 7, 2020 -- A new universal influenza vaccine has been developed that targets the stalk portion of the influenza virus surface protein rather than the head portion. This vaccine, which is capable of neutralizing diverse strains of influenza, was evaluated in a phase I clinical study whose results were published in Nature Medicine on December 7. Read More
Regulatory Roundup: Designations come through before year's end
December 7, 2020 -- This week's Regulatory Roundup covers activities from November 30 to December 4 and is filled with breakthrough, orphan, and rare disease designations from the U.S. Food and Drug Administration and the European Medicines Agency. Several cancer, immunotherapy, and vaccine companies also submitted biologic license applications to move their candidates forward. Read More
Thermo Fisher reports high revenues in Q2
July 28, 2021 -- Thermo Fisher Scientific reported a significant revenue increase during the second quarter of 2021. Read More
Eurekare introduces awards to support synthetic biology
July 28, 2021 -- Eurekare has launched Eurekawards, a competition aimed at discovering and supporting ambitious synthetic biology projects from across Europe. Read More
ImmunityBio COVID-19 oral vaccine effective in nonhuman primates
December 12, 2020 -- ImmunityBio's COVID-19 vaccine candidate has been shown to protect nasal and lung airways of nonhuman primates against SARS-CoV-2 in preclinical studies. Read More
Google's DeepMind makes a quantum leap in solving the protein folding problem
December 11, 2020 -- Artificial intelligence has made something of a breakthrough in the prediction of protein structures. The results came about as part of the 14th Critical Assessment of Structure Prediction, a friendly contest and conference organized by the Protein Structure Prediction Center with sponsorship from the National Institute of General Medical Sciences, part of the U.S. National Institutes of Health. Read More
AI tracks cell movements in stem cell colonies
May 17, 2021 -- Scientists are still trying to understand how stem cell clusters assemble to form complex organs. To help demystify this phenomenon, researchers developed an ensemble of cell-tracking algorithms to track the movements in colonies of human induced pluripotent stem cells. The research demonstrates the potential of artificial intelligence (AI) in developmental biology. Read More
Sanofi, GSK COVID-19 vaccine to advance to phase III trials
May 17, 2021 -- Sanofi and GlaxoSmithKline's (GSK's) adjuvanted, recombinant COVID-19 vaccine candidate produced strong rates of neutralizing antibody responses in all adult age groups in a phase II study with 722 volunteers. Now the firms are advancing to a phase III study that is expected to start in the coming weeks. Read More

usemap Join Us
Conferences
Cell Bio 2022
December 3-7
District of Columbia United States
Glasgow International Health Festival
January 25-26, 2023
Glasgow
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter
Latest Tweets